Zenas BioPharma, Inc.
ZBIO
$32.34
-$0.71-2.15%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 643.13M | 717.21M | 343.19M | 290.88M | 273.28M |
| Total Receivables | 800.00K | 1.10M | 1.20M | 1.30M | 1.30M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 9.87M | 11.86M | 6.78M | 4.46M | 4.02M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 653.79M | 730.16M | 351.17M | 296.64M | 278.60M |
|
|
|||||
| Total Current Assets | 653.79M | 730.16M | 351.17M | 296.64M | 278.60M |
| Net Property, Plant & Equipment | 844.00K | 1.12M | 1.39M | 857.00K | 1.07M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 16.29M | 15.06M | 13.81M | 13.80M | 11.80M |
| Total Assets | 701.69M | 747.68M | 383.64M | 322.02M | 293.09M |
|
|
|||||
| Total Accounts Payable | 7.59M | 8.94M | 7.11M | 6.44M | 7.93M |
| Total Accrued Expenses | 57.41M | 51.06M | 54.31M | 45.36M | 44.52M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 823.00K | 1.04M | 1.12M | 618.00K | 793.00K |
| Total Finance Division Other Current Liabilities | -- | 118.00K | 118.00K | -- | -- |
| Total Other Current Liabilities | -- | 118.00K | 118.00K | -- | -- |
| Total Current Liabilities | 65.82M | 61.16M | 62.65M | 52.42M | 53.24M |
|
|
|||||
| Total Current Liabilities | 65.82M | 61.16M | 62.65M | 52.42M | 53.24M |
| Long-Term Debt | 297.02M | 265.72M | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 22.00K | 77.00K | 211.00K | 180.00K | 215.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 91.74M | 84.90M | 78.64M | 72.99M | -- |
| Total Liabilities | 454.59M | 411.85M | 141.50M | 125.59M | 53.46M |
|
|
|||||
| Common Stock & APIC | 1.21B | 1.18B | 1.01B | 721.18M | 712.91M |
| Retained Earnings | -957.57M | -846.12M | -765.13M | -524.69M | -473.19M |
| Treasury Stock & Other | -1.14M | -377.00K | -64.00K | -69.00K | -94.00K |
| Total Common Equity | 247.10M | 335.83M | 242.14M | 196.43M | 239.63M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 247.10M | 335.83M | 242.14M | 196.43M | 239.63M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 247.10M | 335.83M | 242.14M | 196.43M | 239.63M |
|
|
|||||